Cutler Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $4K | Hold |
3,100
| – | – | ﹤0.01% | 745 |
|
|
2023
Q4 | $2K | Hold |
3,100
| – | – | ﹤0.01% | 1206 |
|
|
2023
Q3 | $3K | Hold |
3,100
| – | – | ﹤0.01% | 1234 |
|
|
2023
Q2 | $8K | Hold |
3,100
| – | – | ﹤0.01% | 1037 |
|
|
2023
Q1 | $12K | Buy |
3,100
+1,000
| +48% | +$3.87K | ﹤0.01% | 982 |
|
|
2022
Q4 | $10K | Buy |
2,100
+700
| +50% | +$3.33K | ﹤0.01% | 1295 |
|
|
2022
Q3 | $18K | Buy |
1,400
+1,300
| +1,300% | +$16.7K | ﹤0.01% | 1217 |
|
|
2022
Q2 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 1825 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2741 |
|
|
2021
Q4 | – | Sell |
-1,800
| Closed | -$37K | – | 2802 |
|
|
2021
Q3 | $37K | Buy |
1,800
+800
| +80% | +$16.4K | ﹤0.01% | 1317 |
|
|
2021
Q2 | $19K | Sell |
1,000
-1,100
| -52% | -$20.9K | ﹤0.01% | 1555 |
|
|
2021
Q1 | $61K | Buy |
2,100
+100
| +5% | +$2.91K | ﹤0.01% | 1081 |
|
|
2020
Q4 | $60K | Buy |
2,000
+1,600
| +400% | +$48K | ﹤0.01% | 940 |
|
|
2020
Q3 | $6K | Hold |
400
| – | – | ﹤0.01% | 1417 |
|
|
2020
Q2 | $7K | Buy |
+400
| New | +$7K | ﹤0.01% | 1296 |
|